跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DESVENLAFAXINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DESVENLAFAXINE
Authorized
STANDARD
DESVENLAFAXINE
SANIS HEALTH INC
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
a0478e37b5c3642a
Company
SANIS HEALTH INC
Type
Standard
Approval Details
Approval Id
a0478e37b5c3642a
Drug Approval Canada Name
DESVENLAFAXINE
Product Name
DESVENLAFAXINE
Status
Marketed
Status Date
2023-05-25
Original Market Date
2023-05-25
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.16
Atc Original
N06AX23 DESVENLAFAXINE
Aig Number
0152509002
Company Name
SANIS HEALTH INC
Company Address
1 Presidents Choice Circle Brampton Ontario Canada L6Y 5S5
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
a0478e37b5c3642a
Type
Standard
Back to Health Canada Approvals